$2.46
-0.09 (-3.35%)
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+473.9% upside
Low Target
$7.81
Average Target
$14.09
High Target
$15.42
Current Price
$2.46
Current
$2.46
$2.46
Target
$14.09
$14.09
$7.81
$14.09 avg
$15.42
Scenario Analysis
Bear Case
$7.81
218.1%
Low target
Base Case
$14.09
+473.9%
Avg target
Bull Case
$15.42
+528.1%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$7.65
-67.9% from high
52-Week Low
$3.91
+-37.2% from low
Target vs 52W High
$14.09
+84.2% vs high
Next Earnings Report
Nov 16, 2026
2d
until earnings
EPS Est: $-0.16
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -12.5% |
| AMGN | Hold | 42 | 43% | $190.87 | -59.0% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +115.9% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.2% |
| MRNA | Hold | 31 | 32% | $149.45 | -35.4% |
| REGN | Buy | 36 | 72% | $76.80 | -91.9% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -55.7% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -35.3% |